To elucidate the direct influence of nitroglycerin on coronary collateral function in patients and to clarify the relation between angiographic appearance and functional peiformance of coronary collaterals, we measured retrograde flow and peripheral coronary pressure (PCP) 
alterations in coronary collateral function; many other factors are capable of influencing the distribution of myocardial blood flow. Angiographic and postmortem descriptions of coronary collateral anatomy frequently have been used to make inferences concerning the functional performance of coronary collateral channels.9-13 Yet these anatomic findings have not been previously correlated with physiologic function. In particular, angiographic assessment of coronary collaterals, an important part of the clinical evaluation of symptomatic coronary disease, has not been systematized by an objective, generally applicable grading system, nor have angiographic findings been compared with independently obtained estimates of coronary collateral function.
Uncertainty regarding the role of coronary collateral function contributes to uncertainty concerning the mechanisms responsible for the beneficial action of nitroglycerin (TNG) in patients with angina pectoris. A number of studies have sugCirculation, Volume XLIX, February 1974 gested that TNG may augment blood flow to ischemic portions of the myocardium.'4-17 Specifically, Fam and McGregor demonstrated that TNG was capable of reducing resistance to collateral blood flow in dogs with chronic coronary occlusions.14 Nevertheless, these animal data do not imply that TNG is equally capable of enhancing collateral blood flow in patients with multivessel coronary occlusive disease. On the contrary, several studies have emphasized TNG-induced changes in peripheral hemodynamics that tend to reduce myocardial oxygen requirements and have suggested that such an action comprises the major mechanism responsible for relief of ischemic pain.18-21 To help resolve these conflicting concepts and to further elucidate the action of TNG in patients, we sought direct measurement of the ability of TNG to influence physiological parameters of coronary collateral function in individuals with coronary disease. Aortocoronary bypass surgery has provided a unique opportunity to examine indices of coronary collateral function in humans with severe, symptomatic, multivessel coronary occlusive disease by permitting access to distal portions of the diseased coronary arterial tree. In the following studies, we have utilized this opportunity to obtain information pertaining to two problems mentioned above: 1) Is nitroglycerin capable of exerting a direct effect relative to aortic pressure is consistent with a TNG-induced increase in the ability of collateral channels to deliver blood flow to potentially ischemic regions.
Ideally, assessment of the influence of TNG on coronary collateral function should be made in the absence of associated change in aortic pressure. Preliminary results indicated that TNG, when administered at rates insufficient to lower aortic pressure, also failed to alter coronary collateral resistance. Therefore, in eight patients TNG-induced reduction in aortic pressure was attenuated by adjustment of the rate of systemic blood flow ( fig. 6, left) . In contrast to results found when aortic pressure was permitted to fall, measurements after TNG with aortic pressure held constant revealed a consistent and sometimes dramatic rise in retrograde flow ( fig. 6 
